中文名 | (4,6-二甲基嘧啶-2-基)甲醇 |
---|---|
英文名 | (4,6-dimethylpyrimidin-2-yl)methanol |
英文别名 |
4.6-Dimethylpyrimidin-2-yl-methanol
(4,6-Dimethyl-2-pyrimidinyl)methanol 4,6-dimethyl-2-pyrimidinemethanol (4,6-dimethylpyrimidin-2-yl)methanol 2-Pyrimidinemethanol, 4,6-dimethyl- 2-Pyrimidinemethanol,4,6-dimethyl-(9CI) 4,6-dimethylpyrimidine-2-methanol (4,6-Dimethyl-pyrimidin-2-yl)-methanol |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 235.1±28.0 °C at 760 mmHg |
分子式 | C7H10N2O |
分子量 | 138.167 |
闪点 | 96.0±24.0 °C |
精确质量 | 138.079315 |
PSA | 46.01000 |
LogP | 0.07 |
蒸汽压 | 0.0±0.5 mmHg at 25°C |
折射率 | 1.543 |
储存条件 | 2-8°C,保存于惰性气体中 |
海关编码 | 2933599090 |
---|
~% 54198-72-0 |
文献:ARROW THERAPEUTICS LIMITED; ASTRAZENECA UK LIMITED; BARNES, Michael, Christopher, Stratton; FLACK, Stephen, Sean; FRASER, Ian; LUMLEY, James, Andrew; PANG, Pui Shan; SPENCER, Keith, Charles; TIBERGHIEN, Nathalie, Anne, Laure; TOMKINSON, Gary, Peter Patent: WO2011/151651 A1, 2011 ; Location in patent: Page/Page column 78-79 ; WO 2011/151651 A1 |
~% 54198-72-0 |
文献:ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew, J.; BURSAVICH, Matthew, Gregory Patent: WO2013/142269 A1, 2013 ; Location in patent: Paragraph 0589; 0590; 0591 ; |
~94% 54198-72-0 |
文献:Sakamoto, Takao; Tanji, Ken-Ichi; Niitsuma, Setsuko; Ono, Takayasu; Yamanaka, Hiroshi Chemical and Pharmaceutical Bulletin, 1980 , vol. 28, # 11 p. 3362 - 3368 |
~% 54198-72-0 |
文献:ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew, J.; BURSAVICH, Matthew, Gregory Patent: WO2013/142269 A1, 2013 ; |
~% 54198-72-0 |
文献:ARROW THERAPEUTICS LIMITED; ASTRAZENECA UK LIMITED; BARNES, Michael, Christopher, Stratton; FLACK, Stephen, Sean; FRASER, Ian; LUMLEY, James, Andrew; PANG, Pui Shan; SPENCER, Keith, Charles; TIBERGHIEN, Nathalie, Anne, Laure; TOMKINSON, Gary, Peter Patent: WO2011/151651 A1, 2011 ; WO 2011/151651 A1 |
上游产品 5 | |
---|---|
下游产品 3 | |
海关编码 | 2933599090 |
---|---|
中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |